Rathindra N. Bose, Ph.D., University of Houston

 

 

Vice Chancellor and Vice President of 

UH Research and Technology Transfer

 

 

 

 Rathindra Bose received his Ph.D. degree in chemistry from Georgetown University, Washington D.C., in 1982. Currently he is serving as the Vice Chancellor and Vice President for Research and Technology Transfer at the University of Houston System and University of Houston. He holds a tenured professorial appointment in the department Chemistry.  He has served as the Vice President for Research at Kent State, Northern Illinois, and Ohio University prior to joining The University of Houston. During his tenure, Bose served with distinction both as a faculty member and as an administrator. He received a distinguished scholar award and four outstanding/distinguished teaching awards.  He was also nominated by Kent State University for the 1997 CASE U.S. Professor of the year award. He has created a new class of anticancer agents Phosphaplatins that exhibits superior efficacy with reduced toxicity in preclinical experiments compared to existing platinum anticancer drugs.   A New York based Biotechnology Company, Phosplatin Therapeutics, has licensed his anticancer agents.

 

His notable administrative accomplishments include the creation of new multidisciplinary research institutes, two multidisciplinary doctoral programs, a significant increase of extramural funding, increase of royalty income, creation of spin-off companies based on university technology,   creation  or revision of research policies (conflicts of interest, research misconduct, and intellectual property), implementation of electronic research administration, addition of new research facilities & infrastructure, recruitment of many highly talented faculty, revision of tenure & promotion policies, and service as the assistant chair for the university wide tenure-promotion committee.

 

  He has published extensively in his own field as well as interdisciplinary/multidisciplinary areas that extend to chemical & structural biology and materials science. He has delivered numerous talks as an invited symposium and plenary speaker both at national & international meetings. He has successfully supervised dissertations and theses of 14 Ph.D. and several M.S. students.  His research has been supported through several grants from the National Science Foundation, National Institutes of Health, Ohio Board of Regents, and the U.S. Department of Education.  Dr. Bose has served as a reviewer for funding agencies, a reviewer for more than fifteen international journals, an ad hoc member of the Metallobiochemistry Study Section at NIH, a panel member for the NSF, and a member of the editorial boards of three journals. He is currently serving as the chair of the Science Advisory Board of Phosplatin Therapeutics, and recently served as a board member for Bio-Ohio and Southern Ohio Creates Company (SOCC). Bio-Ohio has the responsibility to attract and support biotech companies in Ohio.  

 

Parking is located in the John P. McGovern Texas Medical Center Commons and will be validated.